Read More Medical Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug Apr 05, 2025
Read More Apparatus World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy! Apr 04, 2025
Read More Apparatus J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Apr 06, 2025